Quick Answer
Neuphoria Therapeutics Inc. reported Earnings Per Share Diluted of $0.23 (loss) per share for the year ending 2025.
- Neuphoria Therapeutics Inc. showed an increase of +98.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Neuphoria Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Neuphoria Therapeutics Inc.'s Earnings Per Share Diluted has declined by 1,050.0%.
- Historical annual values: Fiscal year 2025: $0.23 (loss) per share | Fiscal year 2024: $18.62 (loss) per share | Fiscal year 2023: $0.02 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: